Regenerative Medical Technology RMTG
OTC RMTG
$0.06 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Regenerative Medical Technology (RMTG) Non Operating Interest Expenses (2018 - 2026)

Updated

Regenerative Medical Technology's Non Operating Interest Expenses came in at $2.23 million for Q2 2026, up 111.7% from $1.06 million a year earlier and up 2.0% from the prior quarter.

Analysis

Regenerative Medical Technology (RMTG) Non Operating Interest Expenses (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Regenerative Medical Technology reported Non Operating Interest Expenses of $9.92 million, up 156.0% year-over-year; for FY2025, it was $7.45 million, up 32.0% from FY2024.

  • Non Operating Interest Expenses carries a five-year compound annual growth rate of 12.1% (FY2020 to FY2025).
  • Going back by year, Non Operating Interest Expenses was $5.64 million in FY2024 (-13.1%), $6.49 million in FY2023 and $2.72 million in FY2021 (-35.2%).
  • The five-year range for quarterly Non Operating Interest Expenses is $895,850 (Q1 2025) to $3.49 million (Q3 2025).
  • Year-over-year, Non Operating Interest Expenses has increased for four consecutive quarters, with growth averaging 57.6% over the last eight quarters.
  • The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q3 2025 (growth of 285.5%), and the weakest in Q4 2021 (a decline of 61.2%).
  • Business Quant data shows RMTG's Non Operating Interest Expenses at $2.19 million (Q1 2026), $2.01 million (Q4 2025) and $3.49 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 281.00 Mn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -435.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 247.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Regenerative Medical Technology 824,338.06 -3.70 Mn 2.58 Mn 2.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.23 Mn
Mar 31, 2026 2.19 Mn
Dec 31, 2025 2.01 Mn
Sep 30, 2025 3.49 Mn
Jun 30, 2025 1.06 Mn
Mar 31, 2025 895,850.00
Dec 31, 2024 1.02 Mn
Sep 30, 2024 905,572.00
Jun 30, 2024 1.86 Mn
Mar 31, 2024 1.85 Mn
Dec 31, 2023 1.63 Mn
Sep 30, 2023 1.66 Mn
Sep 30, 2022 1.18 Mn
Jun 30, 2022 1.13 Mn
Mar 31, 2022 1.14 Mn
Dec 31, 2021 1.06 Mn
Sep 30, 2021 900,039.00
Jun 30, 2021 440,457.00
Mar 31, 2021 319,228.00
Dec 31, 2020 2.74 Mn
API Access

Regenerative Medical Technology Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RMTG&period=max&api_key=YOUR_API_KEY